Search
Spotlight
CME Opportunities
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Advanced Ovarian Cancer: New Perspectives on Systemic Therapy
EP. 1: Frontline Treatments in Ovarian Cancer
October 24th 2019
EP. 2: Predictive Biomarkers in Ovarian Cancer
October 24th 2019
EP. 3: Somatic Testing in Ovarian Cancer
October 24th 2019
EP. 4: The Importance of HRD Testing in Ovarian Cancer
October 24th 2019
EP. 5: Combination Veliparib and Chemotherapy in Ovarian Cancer
October 24th 2019
EP. 6: PARP Inhibition in BRCA1/2+ or HRD- Ovarian Cancer
October 24th 2019
EP. 7: Adverse-Effect Profiles of PARP Inhibitors in Ovarian Cancer
October 24th 2019
EP. 8: PARP Inhibitors and Indications in Ovarian Cancer
October 24th 2019
EP. 9: Maintenance Therapy in Ovarian Cancer
October 24th 2019
EP. 10: Treatment of Emergent Adverse Events in Ovarian Cancer
October 24th 2019
EP. 11: Treatment of HRD-Negative Ovarian Cancer
October 24th 2019
EP. 12: New Options for Recurrent Ovarian Cancer
October 24th 2019
EP. 13: Low-Grade Serous Ovarian Cancer
October 24th 2019
EP. 14: Paradigms of Success in Ovarian Cancer
October 24th 2019
x